Merck (MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting ...

(Reuters) -Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for ...

We recently compiled a list of the Jim Cramer Remembers COVID-19 & Discusses These 11 Stocks. In this article, we are going ...

China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price. But this disruptive trend ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.

Eli Lilly and Company, Johnson & Johnson, Pfizer, Merck & Co., Inc., and Novo Nordisk A/S are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. These ...

Merck Life Science opens formulation & technology centre in Turbhe, Navi Mumbai: Our Bureau, Bengaluru Tuesday, February 25, ...

With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be acquired next.

Ligand originated, structured, and invested $50 million and led a syndicate of co-investors who invested $25 million in ...

Merck & Co. is facing a class action lawsuit over Gardasil sales projections. Learn how to recover losses with Levi & ...

Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...